Our researchers combine imagination with the rigor of collaborative science to find better treatments for disease.
Novartis Institutes for BioMedical Research (NIBR)
NIBR is the global pharmaceutical research organization of Novartis. With approximately 6,000 scientists and physicians around the world, our research is focused on discovering innovative new drugs that will change the practice of medicine. We have an open and entrepreneurial culture, encouraging collaboration to make effective therapies. We have an open and entrepreneurial culture, encouraging collaboration internally and externally to make effective therapies. Today, our research benefits from an external network of more than 300 academic and 100 industry alliances focused on areas of mutual scientific interest.
At NIBR, you will have the opportunity to work alongside an extraordinarily talented and diverse group of people from around the globe, all committed to making a difference for our patients and customers.
We have opportunities globally in the following research areas:
Autoimmunity, Transplantation and Inflammation
Cardiovascular, Renal and Metabolism
Analytical and Imaging Sciences
Global Discovery Chemistry
Developmental & Molecular Pathways
Center for Proteomic Chemistry
DMPK and Biomarker Development
Novartis Institute for Tropical Diseases (NITD)
NITD is an established organization that is striving to help end the burden of tropical disease in developing countries. With more than 100 researchers and support staff, NITD focuses its research activities on dengue, tuberculosis and malaria. We will make our treatments readily available without profit to poor patients in developing countries where these diseases are endemic.
NITD recruits the best scientific experts in the world. As a major center of excellence, NITD offers teaching and training opportunities for: